GCMAX
Price
$37.33
Change
+$0.22 (+0.59%)
Updated
Jul 3 closing price
Net Assets
1.09B
VMCPX
Price
$383.04
Change
+$2.26 (+0.59%)
Updated
Jul 3 closing price
Net Assets
185.28B
Interact to see
Advertisement

GCMAX vs VMCPX

Header iconGCMAX vs VMCPX Comparison
Open Charts GCMAX vs VMCPXBanner chart's image
Goldman Sachs Mid Cap Value A
Price$37.33
Change+$0.22 (+0.59%)
VolumeN/A
Net Assets1.09B
Vanguard Mid Cap Index InstitutionalPlus
Price$383.04
Change+$2.26 (+0.59%)
VolumeN/A
Net Assets185.28B
GCMAX vs VMCPX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GCMAX vs. VMCPX commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCMAX is a Buy and VMCPX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMCPX has more cash in the bank: 185B vs. GCMAX (1.09B). VMCPX pays higher dividends than GCMAX: VMCPX (1.54) vs GCMAX (0.68). GCMAX was incepted earlier than VMCPX: GCMAX (28 years) vs VMCPX (15 years). GCMAX (1.20) is less costly to investors than VMCPX (0.03). GCMAX is a more actively managed with annual turnover of: 56.00 vs. VMCPX (16.00). GCMAX has a lower initial minimum investment than VMCPX: GCMAX (1000) vs VMCPX (100000000). VMCPX annual gain was more profitable for investors over the last year : 16.95 vs. GCMAX (5.67). VMCPX return over 5 years is better than : 72.78 vs. GCMAX (32.11).
GCMAXVMCPXGCMAX / VMCPX
Total Expense Ratio1.190.033,967%
Annual Report Gross Expense Ratio1.200.034,000%
Fund Existence28 years15 years-
Gain YTD3.4866.99650%
Front Load6%N/A-
Min. Initial Investment10001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.09B185B1%
Annual Yield % from dividends0.681.5444%
Returns for 1 year5.6716.9533%
Returns for 3 years9.6542.2923%
Returns for 5 years32.1172.7844%
Returns for 10 years-5.10126.27-4%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NUS8.920.10
+1.13%
NuSkin Enterprises
FATE1.12N/A
N/A
Fate Therapeutics
RIOT12.17-0.03
-0.25%
Riot Platforms
UMC7.83-0.03
-0.38%
United Microelectronic Corp
BGLC6.43-0.39
-5.72%
Bionexus Gene Lab Corp